164 related articles for article (PubMed ID: 34277512)
1. 24-Month Clinical, Immuno-Virological Outcomes, and HIV Status Disclosure in Adolescents Living With Perinatally-Acquired HIV in the IeDEA-COHADO Cohort in Togo and Côte d'Ivoire, 2015-2017.
Dassi Tchoupa Revegue MH; Takassi UE; Tanoh Eboua F; Desmonde S; Amoussou-Bouah UB; Bakai TA; Jesson J; Dahourou DL; Malateste K; Aka-Dago-Akribi H; Raynaud JP; Arrivé E; Leroy V
Front Pediatr; 2021; 9():582883. PubMed ID: 34277512
[No Abstract] [Full Text] [Related]
2. Notification of HIV status disclosure and its related factors in HIV-infected adolescents in 2009 in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d'Ivoire, The PRADO-CI Study.
Meless GD; Aka-Dago-Akribi H; Cacou C; Eboua TF; Aka AE; Oga AM; Bouah B; Eugène M; Moh C; Arrivé E; Timité-Konan M; Leroy V;
J Int AIDS Soc; 2013 Jun; 16(1):18569. PubMed ID: 23782475
[TBL] [Abstract][Full Text] [Related]
3. Disparities in access to Dolutegravir in West African children, adolescents and young adults aged 0-24 years living with HIV. A IeDEA Pediatric West African cohort analysis.
Desmonde S; Dame J; Malateste K; David A; Amorissani-Folquet M; N'Gbeche S; Sylla M; Takassi E; Kouakou K; Tossa LB; Yonaba C; Leroy V;
medRxiv; 2024 Jun; ():. PubMed ID: 38826257
[TBL] [Abstract][Full Text] [Related]
4. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.
Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timité-Konan M; Mea V; Ouédraogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V
J Int AIDS Soc; 2017 Apr; 20(1):21362. PubMed ID: 28453240
[TBL] [Abstract][Full Text] [Related]
5. 12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008.
Ekouevi DK; Azondekon A; Dicko F; Malateste K; Touré P; Eboua FT; Kouadio K; Renner L; Peterson K; Dabis F; Sy HS; Leroy V;
BMC Public Health; 2011 Jun; 11():519. PubMed ID: 21718505
[TBL] [Abstract][Full Text] [Related]
6. Predictors and consequences of HIV status disclosure to adolescents living with HIV in Eastern Cape, South Africa: a prospective cohort study.
Edun O; Shenderovich Y; Zhou S; Toska E; Okell L; Eaton JW; Cluver L
J Int AIDS Soc; 2022 May; 25(5):e25910. PubMed ID: 35543100
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study.
Frigati LJ; Wilkinson KA; le Roux S; Brown K; Ruzive S; Githinji L; Petersen W; Belard S; Cotton MF; Myer L; Zar HJ
J Int AIDS Soc; 2021 Mar; 24(3):e25671. PubMed ID: 33719199
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy incidence and associated factors among HIV-infected female adolescents in HIV care in urban Côte d'Ivoire, 2009-2013.
Arikawa S; Eboua T; Kouakou K; N'Gbeche MS; Amorissani-Folquet M; Moh C; Amoussou-Bouah UB; Coffie PA; Becquet R; Leroy V;
Glob Health Action; 2016; 9():31622. PubMed ID: 27527503
[TBL] [Abstract][Full Text] [Related]
9. HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa.
Arrivé E; Dicko F; Amghar H; Aka AE; Dior H; Bouah B; Traoré M; Ogbo P; Dago-Akribi HA; Eboua TK; Kouakou K; Sy HS; Alioum A; Dabis F; Ekouévi DK; Leroy V;
PLoS One; 2012; 7(3):e33690. PubMed ID: 22457782
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.
Ndondoki C; Dicko F; Ahuatchi Coffie P; Kassi Eboua T; Ekouevi DK; Kouadio K; Edmond Aka A; Malateste K; Dabis F; Amani-Bosse C; Toure P; Leroy V;
J Int AIDS Soc; 2014; 17(1):18737. PubMed ID: 24894377
[TBL] [Abstract][Full Text] [Related]
11. Disclosure of HIV status and adherence to antiretroviral treatment in children and adolescents from Lomé and Abidjan.
Bakai TA; Iwaz J; Takassi EO; Thomas A; Eboua TKF; Khanafer N; Kenao T; Goilibe KB; Sewu E; Voirin N
Pan Afr Med J; 2023; 45():13. PubMed ID: 37426461
[TBL] [Abstract][Full Text] [Related]
12. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ouédraogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ouédraogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timité-Konan M; Leroy V;
BMC Med; 2017 Apr; 15(1):85. PubMed ID: 28434406
[TBL] [Abstract][Full Text] [Related]
13. Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults.
Messou E; Gabillard D; Moh R; Inwoley A; Sorho S; Eholié S; Rouet F; Seyler C; Danel C; Anglaret X
Bull World Health Organ; 2008 Jun; 86(6):435-42. PubMed ID: 18568272
[TBL] [Abstract][Full Text] [Related]
14. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
15. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.
Djomand G; Roels T; Ellerbrock T; Hanson D; Diomande F; Monga B; Maurice C; Nkengasong J; Konan-Koko R; Kadio A; Wiktor S; Lackritz E; Saba J; Chorba T
AIDS; 2003 Jul; 17 Suppl 3():S5-15. PubMed ID: 14565604
[TBL] [Abstract][Full Text] [Related]
16. Qualitative Study on the Voices of Adolescents Living with Perinatally Acquired HIV in Selected Clinics in the Limpopo Province of South Africa.
Mabasa RA; Muthelo L; Skaal L; Mothiba TM
Children (Basel); 2023 Dec; 11(1):. PubMed ID: 38255342
[TBL] [Abstract][Full Text] [Related]
17. Acceptance of HIV in Cote d'Ivoire earns praise.
AIDS Wkly Plus; 1996 Apr; ():15-6. PubMed ID: 12290906
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
[TBL] [Abstract][Full Text] [Related]
19. Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study.
Nyakato P; Schomaker M; Fatti G; Tanser F; Euvrard J; Sipambo N; Fox MP; Haas AD; Yiannoutsos CT; Davies MA; Cornell M
J Int AIDS Soc; 2022 Jan; 25(1):e25870. PubMed ID: 35032096
[TBL] [Abstract][Full Text] [Related]
20. High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo.
Salou M; Dagnra AY; Butel C; Vidal N; Serrano L; Takassi E; Konou AA; Houndenou S; Dapam N; Singo-Tokofaï A; Pitche P; Atakouma Y; Prince-David M; Delaporte E; Peeters M
J Int AIDS Soc; 2016; 19(1):20683. PubMed ID: 27125320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
